Gliclazide Actavis Dosage & Drug Information

Concise Prescribing Info

Contents

Gliclazide

Indications/Uses

Treatment of maturity-onset diabetes not controlled by diet alone.

Dosage/Direction for Use

Adult 40-320 mg daily.

Administration

Should be taken with food.

Contraindications

Hypersensitivity to sulfonylureas. Porphyria. Liver or kidney disease. Childn. Pregnancy & lactation.

Special Precautions

Infection, surgery, serious injury.

Adverse Reactions

Nausea, headache, fever, hepatitis, photosensitivity skin reactions, jaundice, skin rash, stomach upset, hypoglycaemia symptoms eg, sweating, trembling, weakness, double vision, palpitations, confusion.

View ADR Monitoring Form

Drug Interactions

β-blockers, ACE inhibitors eg, captopril, AIIA eg, losartan, azapropazone & other NSAIDs, sulfinpyrazone, aminoglutethimide, testosterone, co-trimoxazole, fluconazole, nifedipine, loop diuretics, octreotide, rifamycins, lithium, chloramphenicol, cimetidine, clofibrate, corticosteroids, coumarin derivatives, disopyramide, laxatives, MAOIs, oral miconazole, OC, phenothiazine derivatives, phenylbutazone, salicylates, sulfonamides, tetracyclines, diazoxide, thiazide diuretics, thyroid hormones.

MIMS Class

Antidiabetic Agents

ATC Classification

A10BB09 - gliclazide ; Belongs to the class of sulfonylureas. Used in the treatment of diabetes.

Regulatory Classification

P₁S₁S₃

Presentation/Packing

Form

Gliclazide Actavis tab 80 mg

Packing/Price

28's;60's

Gliclazide Actavis

gliclazide

Manufacturer:

Teva

Distributor:

Zuellig

Agencia Lei Va Hong